Open AccessAnti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
Author(s) -
Haibo Zhu,
Haobin Deng,
Juan Mu,
Cuicui Lyu,
Yili Jiang,
Qi Deng
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s312904
Subject(s) - cd22 , medicine , salvage therapy , refractory (planetary science) , cd19 , chimeric antigen receptor , b cell , lymphoma , cd20 , oncology , gastroenterology , antigen , immunology , chemotherapy , immunotherapy , cancer , biology , antibody , astrobiology